Personalized GLP-1 Injectable (Dual-Action)

Tirzepatide • Compounded GLP-1 Therapy

Tirzepatide acts on both GLP-1 and GIP receptor pathways. This provider-supervised compounded injectable is part of a personalized weight management program following an online medical evaluation, with dosing adjusted by your provider over time.

$169 for the first month, $219 thereafter


Dual-mechanism action (GLP-1 + GIP) for comprehensive support.

Personalized titration and progress monitoring by your provider.

Compounded medications are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality.

Monthly delivery through a state-licensed compounding pharmacy.

How It Works

Complete a private online intake, get reviewed by a licensed provider, and receive your personalized tirzepatide plan — shipped monthly from a U.S.-licensed pharmacy.

WHAT PEOPLE ARE SAYING

“Individuals living with obesity deserve effective and safe treatment options that can help restore their weight to levels that support optimal health.”

— Dr. Ania Jastreboff, Yale School of Medicine, lead investigator of the SURMOUNT-1 tirzepatide trial (New England Journal of Medicine). Individual results may vary.

FREQUENTLY ASKED QUESTIONS